These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 35415751)

  • 41. HNRNP I promotes IRAK1 degradation to reduce podocyte apoptosis and inflammatory response alleviating renal injury in diabetic nephropathy.
    Rao Z; Ao G; Zhang Y; Jiang Z; Li L; Hua Z
    Immunobiology; 2024 Sep; 229(5):152835. PubMed ID: 38986278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
    Zhang J; Fu H; Xu Y; Niu Y; An X
    J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy.
    Mukhi D; Nishad R; Menon RK; Pasupulati AK
    Front Med (Lausanne); 2017; 4():102. PubMed ID: 28748185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glomerular podocytes in diabetic renal disease.
    Podgórski P; Konieczny A; Lis Ł; Witkiewicz W; Hruby Z
    Adv Clin Exp Med; 2019 Dec; 28(12):1711-1715. PubMed ID: 31851794
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PFKP Activation Ameliorates Foot Process Fusion in Podocytes in Diabetic Kidney Disease.
    Zhang Z; Liang W; Luo Q; Hu H; Yang K; Hu J; Chen Z; Zhu J; Feng J; Zhu Z; Chi Q; Ding G
    Front Endocrinol (Lausanne); 2021; 12():797025. PubMed ID: 35095764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
    Zhang X; Song Z; Guo Y; Zhou M
    Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of the podocyte in albumin filtration.
    Brinkkoetter PT; Ising C; Benzing T
    Nat Rev Nephrol; 2013 Jun; 9(6):328-36. PubMed ID: 23609563
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes.
    Dong D; Fan TT; Ji YS; Yu JY; Wu S; Zhang L
    Int Urol Nephrol; 2019 Apr; 51(4):755-764. PubMed ID: 30734886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Podocyte in Kidney Disease.
    Husain S
    Front Biosci (Landmark Ed); 2024 Jul; 29(7):250. PubMed ID: 39082335
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Histone modification in podocyte injury of diabetic nephropathy.
    Wang S; Zhang X; Wang Q; Wang R
    J Mol Med (Berl); 2022 Oct; 100(10):1373-1386. PubMed ID: 36040515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes.
    Yoshibayashi M; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Osawa N; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Asanuma K; Maegawa H; Araki SI
    Biochem Biophys Res Commun; 2020 Apr; 525(2):319-325. PubMed ID: 32089264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases.
    Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y
    BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria.
    Jauregui A; Mintz DH; Mundel P; Fornoni A
    Curr Opin Nephrol Hypertens; 2009 Nov; 18(6):539-45. PubMed ID: 19724224
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
    Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
    J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
    Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
    Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
    Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
    Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.